Therapeutic apheresis for renal diseases.
Plasma exchange is used frequently in renal diseases for the removal of the humoral components of immune responses. Various pathological circulating factors are recognized in primary and secondary renal diseases. Recent advances in medical technology have allowed a wider clinical application of plasmapheresis in the clinical management of a variety of conditions. However, the clinical efficacy of plasmapheresis in renal diseases is still controversial. In this article, we review the therapeutic use of apheresis in different renal diseases.
Harada
T
T
Miyazaki
M
M
Ozono
Y
Y
Sasaki
O
O
Shioshita
K
K
Kohno
S
S
Nishikido
M
M
Saito
Y
Y
Taguchi
T
T
D019867:Anti-Glomerular Basement Membrane Disease; D000906:Antibodies / Q000097:blood; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D000917:Antibody Formation / Q000276:immunology; D001485:Basement Membrane / Q000276:immunology; D005922:Glomerulonephritis, IGA / Q000628:therapy; D015433:Glomerulonephritis, Membranous / Q000276:immunology / Q000628:therapy; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology / Q000628:therapy*; D007678:Kidney Glomerulus / Q000276:immunology; D008181:Lupus Nephritis / Q000628:therapy; D010951:Plasma Exchange; D010956:Plasmapheresis / Q000379:methods
D000906:Antibodies; D019268:Antibodies, Antineutrophil Cytoplasmic